Klinische Studie

A Study to Predict Atrial Fibrillation (AF) Burden in Participants With PAF and PsAF Treated With the VARIPULSE™ PFA Catheter

NCT: NCT07788989 · NOT_YET_RECRUITING

NCT-IDNCT07788989

Medizinische Daten: StatusNOT_YET_RECRUITING

Startdatum2026-10-30

Abschluss2029-10-31

SponsorBiosense Webster, Inc. (INDUSTRY)

First posted2026-08-27

Last updated2026-09-15

Kurzzusammenfassung

The purpose of this study is to evaluate how safe VARIPULSE™ Catheter is and how well it works in the treatment of participants with symptomatic paroxysmal atrial fibrillation (PAF; irregular heartbeat where episodes start and stop on their own, usually within seven days) and symptomatic persistent atrial fibrillation (PsAF; irregular, rapid heartbeat that lasts more than 7 days and doesn't stop on its own).

Offizielle Quelle

Auf ClinicalTrials.gov ansehen →

Daten aus der ClinicalTrials.gov-API. Den aktuellsten Status finden Sie im offiziellen Eintrag.